UNDA 295 (Seroyal USA)
Welcome to the PulseAid listing for the UNDA 295 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Seroyal USA |
| NON-PROPRIETARY NAME: | Pulsatilla, Nux vomica, Aloe socotrina |
| SUBSTANCE NAME: | STRYCHNOS NUX-VOMICA SEED; ALOE; PULSATILLA VULGARIS |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-05-27 |
| END MARKETING DATE: | 0000-00-00 |
UNDA 295 HUMAN OTC DRUG Details:
| Item Description | UNDA 295 from Seroyal USA |
| LABELER NAME: | Seroyal USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4; 6; 4([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL) |
| START MARKETING DATE: | 2015-05-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62106-1168_5a950ca4-3522-9120-e053-2991aa0aacb2 |
| PRODUCT NDC: | 62106-1168 |
| APPLICATION NUMBER: | |
Other STRYCHNOS NUX-VOMICA SEED; ALOE; PULSATILLA VULGARIS Pharmaceutical Manufacturers / Labelers:
